Company News

Share this article:

Gilead Sciences Inc. has agreed to pay $1.4 billion, or $20 a share, for CV Therapeutics, a manufacturer of chest pain and heart drugs. The bid tops Astellas' $16-a-share bid for CV Therapeutics, announced last January.

 

GSW Worldwide's Pink Tank, an agency specializing in health marketing to women, has launched a new web site: www.knowher.com. The site provides information about strategic consulting services for clients who want to reach women consumers.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Janssen recruits Debbie Allen for T2 Diabetes

Actress, choreographer and "So You Think You Can Dance" judge Debbie Allen has signed on to participate with the drugmaker's type 2 diabetes awareness and wellness program.

Pfizer seeks wider Xeljanz indication

The company expects to file an sNDA for plaque psoriasis next year.

Recalls dent Stryker Q1 earnings

Sales rose 5% compared to the same period last year.